Schroder Investment Management Group Catalent, Inc. Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

A detailed history of Schroder Investment Management Group transactions in Catalent, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 4,207 shares of CTLT stock, worth $267,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,207

Holding current value

$267,060

% of portfolio

0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$56.16 - $60.96 $236,265 - $256,458	4,207 New	4,207 $254,000
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $13.1 Million - $18.4 Million	-306,931 Reduced 23.06%	1,024,331 $57.8 Million
Q4 2023 Feb 13, 2024	SELL	$32.18 - $46.57 $129,395 - $187,257	-4,021 Reduced 0.3%	1,331,262 $59.8 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $4.56 Million - $5.18 Million	103,241 Added 8.38%	1,335,283 $60.8 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $9.34 Million - $19.7 Million	293,146 Added 31.22%	1,232,042 $53.4 Million
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $8.91 Million - $14.6 Million	195,988 Added 26.38%	938,896 $61.7 Million
Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $7.38 Million - $14.4 Million	178,373 Added 31.6%	742,908 $33.4 Million
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $2.81 Million - $4.39 Million	-38,773 Reduced 6.43%	564,535 $40.9 Million
Q2 2022 Aug 11, 2022	SELL	$87.2 - $114.05 $1.16 Million - $1.52 Million	-13,337 Reduced 2.16%	603,308 $64.7 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $9.64 Million - $12.7 Million	-102,323 Reduced 14.23%	616,645 $68.3 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $2.72 Million - $3.17 Million	-22,759 Reduced 3.07%	718,968 $92 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $12.6 Million - $16.4 Million	-115,409 Reduced 13.46%	741,727 $98.7 Million
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $16.5 Million - $19 Million	-163,948 Reduced 16.06%	857,136 $92.7 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $3.33 Million - $4.11 Million	-32,790 Reduced 3.11%	1,021,084 $108 Million
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $37 Million - $45.4 Million	-430,655 Reduced 29.01%	1,053,874 $110 Million
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $19.9 Million - $25.2 Million	-272,958 Reduced 15.53%	1,484,529 $127 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $2.06 Million - $3.4 Million	-42,982 Reduced 2.39%	1,757,487 $129 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $9.36 Million - $15.9 Million	-253,193 Reduced 12.33%	1,800,469 $94.3 Million
Q4 2019 Feb 11, 2020	BUY	$47.06 - $56.64 $15.5 Million - $18.7 Million	330,047 Added 19.15%	2,053,662 $116 Million
Q3 2019 Nov 12, 2019	SELL	$47.45 - $58.05 $4.54 Million - $5.56 Million	-95,736 Reduced 5.26%	1,723,615 $81.8 Million
Q2 2019 Aug 08, 2019	SELL	$39.26 - $54.21 $29.6 Million - $40.9 Million	-753,796 Reduced 29.29%	1,819,351 $98.6 Million
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $6.58 Million - $9.68 Million	-220,391 Reduced 7.89%	2,573,147 $104 Million
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $4.26 Million - $6.59 Million	-142,314 Reduced 4.85%	2,793,538 $87.1 Million
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $883,322 - $1 Million	-22,017 Reduced 0.74%	2,935,852 $134 Million
Q2 2018 Aug 24, 2018	BUY	$38.72 - $42.52 $69.7 Million - $76.5 Million	1,799,638 Added 155.38%	2,957,869 $122 Million
Q2 2018 Aug 13, 2018	SELL	$38.72 - $42.52 $77.4 Million - $85 Million	-1,998,744 Reduced 63.31%	1,158,231 $77.3 Million
Q1 2018 May 11, 2018	SELL	$39.4 - $47.39 $21.9 Million - $26.3 Million	-555,194 Reduced 14.96%	3,156,975 $130 Million
Q4 2017 Feb 09, 2018	SELL	$37.27 - $43.02 $15.5 Million - $17.8 Million	-414,847 Reduced 10.05%	3,712,169 $152 Million
Q3 2017 Nov 09, 2017	BUY	$33.75 - $41.67 $139 Million - $172 Million	4,127,016	4,127,016 $163 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Catalent, Inc. Transaction History